JP2015520628A5 - - Google Patents

Download PDF

Info

Publication number
JP2015520628A5
JP2015520628A5 JP2015509510A JP2015509510A JP2015520628A5 JP 2015520628 A5 JP2015520628 A5 JP 2015520628A5 JP 2015509510 A JP2015509510 A JP 2015509510A JP 2015509510 A JP2015509510 A JP 2015509510A JP 2015520628 A5 JP2015520628 A5 JP 2015520628A5
Authority
JP
Japan
Prior art keywords
drug delivery
delivery system
implant
lacrimal implant
lacrimal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015509510A
Other languages
English (en)
Japanese (ja)
Other versions
JP6213560B2 (ja
JP2015520628A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2013/000694 external-priority patent/WO2013164671A1/en
Publication of JP2015520628A publication Critical patent/JP2015520628A/ja
Publication of JP2015520628A5 publication Critical patent/JP2015520628A5/ja
Application granted granted Critical
Publication of JP6213560B2 publication Critical patent/JP6213560B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015509510A 2012-05-03 2013-02-27 薬剤送達システムならびに開放隅角緑内障および高眼圧症を治療する方法 Active JP6213560B2 (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201261642287P 2012-05-03 2012-05-03
US61/642,287 2012-05-03
US201261644401P 2012-05-08 2012-05-08
US201261644397P 2012-05-08 2012-05-08
US61/644,401 2012-05-08
US61/644,397 2012-05-08
US201261659921P 2012-06-14 2012-06-14
US61/659,921 2012-06-14
US201261680641P 2012-08-07 2012-08-07
US61/680,641 2012-08-07
US201261717615P 2012-10-23 2012-10-23
US61/717,615 2012-10-23
PCT/IB2013/000694 WO2013164671A1 (en) 2012-05-03 2013-02-27 Drug delivery system and methods of treating open angle glaucoma and ocular hypertension

Publications (3)

Publication Number Publication Date
JP2015520628A JP2015520628A (ja) 2015-07-23
JP2015520628A5 true JP2015520628A5 (cg-RX-API-DMAC7.html) 2016-04-14
JP6213560B2 JP6213560B2 (ja) 2017-10-18

Family

ID=49514247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015509510A Active JP6213560B2 (ja) 2012-05-03 2013-02-27 薬剤送達システムならびに開放隅角緑内障および高眼圧症を治療する方法

Country Status (7)

Country Link
EP (1) EP2844224B1 (cg-RX-API-DMAC7.html)
JP (1) JP6213560B2 (cg-RX-API-DMAC7.html)
CN (1) CN105473130A (cg-RX-API-DMAC7.html)
CA (1) CA2872338C (cg-RX-API-DMAC7.html)
HK (1) HK1222810A1 (cg-RX-API-DMAC7.html)
IN (1) IN2014DN09713A (cg-RX-API-DMAC7.html)
WO (1) WO2013164671A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012021107A2 (en) 2010-08-12 2012-02-16 Nanyang Technological University A liposomal formulation for ocular drug delivery
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery
GB201714392D0 (en) * 2017-09-07 2017-10-25 Marsteller Laurence Methods and devices for treating glaucoma

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321108A (en) 1965-11-26 1967-05-23 William E Bowe Printing ink dispenser
US3681608A (en) 1971-03-17 1972-08-01 Us Navy Laser beam receiver having a high signal to noise ratio
US4281654A (en) 1980-04-07 1981-08-04 Alza Corporation Drug delivery system for controlled ocular therapy
US4952581A (en) 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
US4936008A (en) 1988-05-09 1990-06-26 Teledyne Mec Laser striping method for assembling TWT
US4934708A (en) 1988-05-20 1990-06-19 Kolkind Gerald L Family quiz board game
US5296504A (en) 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5259508A (en) 1992-08-27 1993-11-09 Beckerman Stephen M Protective shipping package
ES2105333T3 (es) 1992-10-13 1997-10-16 Alcon Lab Inc Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.
US6622308B1 (en) 1999-03-23 2003-09-16 Scientific-Atlanta, Inc. Automatic digital television (DTV) bypass for a CATV converter using a CATV tuner
US6534693B2 (en) 2000-11-06 2003-03-18 Afmedica, Inc. Surgically implanted devices having reduced scar tissue formation
US7300364B2 (en) 2004-02-06 2007-11-27 Acushnet Company Multi-layer golf ball having velocity gradient from faster center to slower cover
WO2004075781A2 (en) 2003-02-26 2004-09-10 Medivas, Llc Bioactive stents and methods for use thereof
JP4104137B2 (ja) * 2003-05-30 2008-06-18 有限会社エム・エル・シー 涙点プラグ
US7662864B2 (en) 2003-06-04 2010-02-16 Rutgers, The State University Of New Jersey Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent
US20050129731A1 (en) 2003-11-03 2005-06-16 Roland Horres Biocompatible, biostable coating of medical surfaces
EP3643702A1 (en) 2004-01-05 2020-04-29 Nicox S.A. Prostaglandin derivatives
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
US7922702B2 (en) 2004-07-02 2011-04-12 Qlt Inc. Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device
CA2648066C (en) 2006-03-31 2012-07-03 Forsight Labs, Llc Drug delivery methods, structures, and compositions for nasolacrimal system
KR20090102810A (ko) * 2006-12-26 2009-09-30 큐엘티 플러그 딜리버리, 인코포레이티드 시력 결함을 억제하기 위한 약물 전달 임플란트
UY30883A1 (es) 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
MX2010002617A (es) 2007-09-07 2010-06-01 Qlt Plug Delivery Inc Implantes lagrimales y metodos relacionados.
KR20100067099A (ko) 2007-09-07 2010-06-18 큐엘티 플러그 딜리버리, 인코포레이티드 눈물 임플랜트 검출
CN101969897A (zh) 2007-09-07 2011-02-09 Qlt栓塞输送公司 用于泪腺植入物的插入和抽出工具
SG184738A1 (en) 2007-09-07 2012-10-30 Quadra Logic Tech Inc Drug cores for sustained release of therapeutic agents
WO2009137085A2 (en) 2008-05-09 2009-11-12 Qlt Plug Delivery, Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
SG173069A1 (en) 2009-01-23 2011-08-29 Quadra Logic Tech Inc Sustained released delivery of one or more agents
SG174133A1 (en) * 2009-02-23 2011-10-28 Quadra Logic Tech Inc Lacrimal implants and related methods
US20120245539A1 (en) 2009-11-27 2012-09-27 Qlt Inc. Lacrimal implants including split and insertable drug core

Similar Documents

Publication Publication Date Title
ES2727203T3 (es) Administración por liberación sostenida de agentes activos para tratar glaucoma e hipertensión ocular
CN102014816B (zh) 泪管植入物及相关方法
JP5415262B2 (ja) 活性剤送達用の涙点プラグ
JP4837861B2 (ja) ドラッグデリバリ製剤
ES2740352T3 (es) Dispositivo ocular
TW200950817A (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension
US20090306608A1 (en) Ophthalmic devices for the controlled release of active agents
JP2009508587A (ja) 眼の処置を提供するための薬剤送達装置および方法
TW201012469A (en) Combination treatment of glaucoma
US20130018360A1 (en) Method for delivering ophthalmic drugs
SI2799064T1 (en) Biodegradable eye implant
TW201043211A (en) Punctal plugs
CA2795699A1 (en) Punctal plugs for controlled release of therapeutic agents
AU2005282894A1 (en) Counter pressure device for ophthalmic drug delivery
AU2005269599A1 (en) Implantable device having reservoir with controlled release of medication and method of manufacturing the same
WO2016031535A1 (ja) 眼瞼内装用具
JP2015520628A5 (cg-RX-API-DMAC7.html)
CN102781452A (zh) 减少与皮质类固醇的眼内使用相关的眼压的发生率的方法
US20220331160A1 (en) Static pin insertion tool for lacrimal implant
TW201304758A (zh) 用於控制治療劑釋放之淚管塞
Campochiaro Pharmacokinetics of sustained-delivery fluocinolone acetonide for DMO
Yong-rong et al. The clinical analysis of posterior capsule rapture during phacoemulsification